Arrowhead Research reported $41.55M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Anika Therapeutics ANIK:US $ -3.55M 5.57M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Cerulean Pharma CERU:US $ -8400450 1.14M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Ligand Pharmaceuticals LGND:US $ -7.81M 20.54M
Merk MRK:US $ 5569M 1994M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Novartis NOVN:VX 2.85B 290M
Opko Health OPK:US $ -72.42M 9.34M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Spectrum Pharmaceuticals SPPI:US $ -14.06M 22.79M
Tg Therapeutics TGTX:US $ -66.87M 26.08M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Xencor XNCR:US $ 26.47M 65.39M
YTE INCY:US $ 116.54M 5.81M